Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Caspofungin acetate infectious data

In an international, double-blind study in 82 patients aged 2 to 17, the incidence of drug-related AEs was 48%

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE